Aeterna Zentaris Insiders
AEZSDelisted Stock | USD 6.14 0.08 1.29% |
Aeterna Zentaris employs about 8 people. The company is managed by 8 executives with a total tenure of roughly 7 years, averaging almost 0.0 years of service per executive, having 1.0 employees per reported executive. Breaking down Aeterna Zentaris' management performance can provide insight into the firm performance.
Michael Teifel President Vice President - Non-Clinical Sciences |
Aeterna |
Aeterna Zentaris Management Team Effectiveness
The company has return on total asset (ROA) of (0.2996) % which means that it has lost $0.2996 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8171) %, meaning that it created substantial loss on money invested by shareholders. Aeterna Zentaris' management efficiency ratios could be used to measure how well Aeterna Zentaris manages its routine affairs as well as how well it operates its assets and liabilities.Aeterna Zentaris Workforce Comparison
Aeterna Zentaris is rated below average in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 350. Aeterna Zentaris holds roughly 8.0 in number of employees claiming about 2.29% of equities under Health Care industry.
Aeterna Zentaris Notable Stakeholders
An Aeterna Zentaris stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Aeterna Zentaris often face trade-offs trying to please all of them. Aeterna Zentaris' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Aeterna Zentaris' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Klaus Paulini | CEO President | Profile | |
ICDD MBA | CEO President | Profile | |
Michael Teifel | Vice President - Non-Clinical Sciences | Profile | |
Giuliano Fratta | Senior CFO | Profile | |
Amlie Mtivier | Assistant Sec | Profile | |
Eckhard Guenther | Sr Germany | Profile | |
Matthias Gerlach | Senior Production | Profile | |
Nicola MD | Chief Development | Profile |
About Aeterna Zentaris Management Performance
The success or failure of an entity such as Aeterna Zentaris often depends on how effective the management is. Aeterna Zentaris management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Aeterna management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Aeterna management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Aeterna Zentaris Inc. was incorporated in 1990 and is headquartered in Summerville, South Carolina. Aeterna Zentaris is traded on NASDAQ Exchange in the United States.
Please note, the imprecision that can be found in Aeterna Zentaris' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Aeterna Zentaris. Check Aeterna Zentaris' Beneish M Score to see the likelihood of Aeterna Zentaris' management manipulating its earnings.
Aeterna Zentaris Workforce Analysis
Traditionally, organizations such as Aeterna Zentaris use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Aeterna Zentaris within its industry.Aeterna Zentaris Manpower Efficiency
Return on Aeterna Zentaris Manpower
Revenue Per Employee | 572.6K | |
Revenue Per Executive | 572.6K | |
Net Loss Per Employee | 2.1M | |
Net Loss Per Executive | 2.1M | |
Working Capital Per Employee | 4M | |
Working Capital Per Executive | 4M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Consideration for investing in Aeterna Stock
If you are still planning to invest in Aeterna Zentaris check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aeterna Zentaris' history and understand the potential risks before investing.
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |